期刊文献+

乳腺癌发病机制的研究:胰岛素样生长因子I型受体表达与Her-2/c-erbB-2及p53的相关性 被引量:2

Pathogenesis of mammary cancer: correlation of the expression of insulin like growth factor I receptor with Her 2/c erbB 2 and p53
下载PDF
导出
摘要 目的:评价乳腺癌胰岛素样生长因子I型受体insulin-likegrowthfac-(tor-Ireceptor,IGF-IR)与雌激素受体(estrogenreceptor,ER,)孕激素受体(progestogenreceptor,PR,Her-2/c-erbB-2,p53表达的相关性,探讨)IGF-IR作为乳腺癌治疗和预后指标的意义。方法:收集120例乳腺癌组织病理石蜡块,用免疫组织化学的方法测定IGF-IR,ER,PR,Her-2/c-erbB-2,p53的表达,将表达程度分为0,1,2,3级,2和3级为高表达。比较它们间的相关关系,用统计学方法进行分析。结果:IGF-IR的表达与ER的表达显著相关(r=0.203,P<0.05)。IGF-IR的表达与PR,Her-2/c-erbB-2,p53的表达无相关性(r=0.040~0.152,P>0.05)。结论IGF-IR的表达与ER的表达存在良好的相关性,IGF-IR可能在乳腺癌发生的内分泌系统中占有重要的地位。IGF-IR的高表达与Her-2/c-erbB-2,p53的表达无相关性,IGF-IR的高表达可能提示较好的预后。 AIM:To evaluate the correlation of the expressions of insulin like growth factor I receptor(IGF IR) with estrogen receptor(ER),progestogen receptor(PR),Her 2/c erbB 2 and p53 of mammary cancer,and investigate the significance of IGF IR as the treatment and the prognostic indexes. METHODS:Totally 120 histological paraffin pieces of mammary cancer were collected.The expressions of IGF IR,ER,PR, Her 2/c erbB 2 and p53 were assayed with immunohistochemical method.The levels of expression were divided into four grades:grades 0,1,2,and 3,of which grades 2 and 3 were defined as overexpression.The correlations of IGF IR with ER,PR,Her 2/c ebB 2 and p53 were compared and analyzed statistically. RESULTS:There was significant correlation between the expressions of IGF IR and ER(r= 0.203,P< 0.05);There was no significant correlation between the expressions of IGF IR and PR,Her 2/c erbB 2 and p53(r=0.040 to 0.152, P >0.05). CONCLUSION:There is a good correlation between the expressions of IGF IR and ER.IGF IR may have an important role in the endocrine system of mammary cancer.There is no correlation between the expressions of IGF IR and Her 2/c erbB 2 and p53,and the overexpression of IGF IR may point out better prognosis.
出处 《中国临床康复》 CSCD 2004年第29期6392-6394,共3页 Chinese Journal of Clinical Rehabilitation
基金 广东省医学科学技术研究基金 A1999339 第一军医大学南方医院院长基金~~
  • 相关文献

参考文献23

  • 1[1]Ciovannucci E. Insulin-like growth factor-Ⅰ and binding protein-3 and risk of cancer. Norm Res 1999; 51:334 -41 被引量:1
  • 2[2]Surmacz E. Function of the IGF-Ⅰ receptor in breast cancer. J Mammary Gland Biol Neoplasia 2000; 5(1): 95 - 105 被引量:1
  • 3[3]Mauro L, Bartucci M, Morelli C. IGF-Ⅰ receptor-induced cell-cell adhesion of MCF-7 breast cancer cells requires the expression of junction proteinZO-1. J Biol Chem 2001; 276(43): 39892 -7 被引量:1
  • 4[4]Guvakova MA, Surmacz E. Overexpressed IGF-Ⅰ receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 1997; 231 (1): 149 -62 被引量:1
  • 5[5]Dunn SE. Torres JV, Oh JS. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-Ⅰ depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res 2001; 61 (4): 1367 - 74 被引量:1
  • 6[6]Takahashi K, Suzuki K. Association of insulin-like growth-factor-Lindu-ced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int J Cancer 1993; 55 (3): 453 - 8 被引量:1
  • 7[7]Espinoza F, Anguiano A. The HercepTest assay: another perspective. J Clin Onco 1999; 17(10) :2293 -4 被引量:1
  • 8[8]Seidman AD, Fornier MN, Esteva FJ, et al. Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 inmunophenotype and gene amplification. J Clin Onco 2001; 19 (10):2587 -95 被引量:1
  • 9贾树华,姜潮,赵耀,王若雨,张杰,William F.Wieczorek.放化疗对乳腺癌妇女性身份和性功能影响的多因素研究[J].中国临床康复,2003,7(21):2926-2929. 被引量:27
  • 10[10]Resnik JL, Reichart DB, Huey K, et al. Elevated insulin-like growth factor Ⅰ receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res 1998;58(6): 1159-64 被引量:1

二级参考文献14

  • 1李润田.乳腺癌普查方法浅析[J].中国慢性病预防与控制,1994,2(1):29-30. 被引量:6
  • 2KOBAYASHI S, INOVE S, HOSOI T, et al. Association of bone mineral density with polymorphism of the estrogen receptor gene[J]. J Bone Miner Res, 1996, 11:306- 311. 被引量:1
  • 3SAMBROOK J. Molecular cloning: a laboratory manual[M]. 3rd ed. New York: Cold Spring Harbor Laboratory, 1989:931- 958. 被引量:1
  • 4SALAMONE L, WOLF R, BLACK D, et al. Association between bone mineral density and the estrogen receptor genotype in premenopausal women[J]. J Bone Miner Res, 1999,14(suppl 1):SA097. 被引量:1
  • 5KIM SW, KIM CH, CHUNG YE, et al. The association of quantitative ultrasound parameters of the calcaneus with vitamin D receptor gene and estrogen receptor gene polymorphism in Korean postmenopausal women[J]. J Bone Miner Res, 2000,15 (suppl 1):SU 107. 被引量:1
  • 6BORI Z, SPEER G, TAKACS I, et al. Interactive effect of vitamin D and estradiol receptor genotype as a depterminant of bone mineral density[J]. J Bone Miner Res, 1999, 14(suppl 1):SA100. 被引量:1
  • 7GOSDEN JR,MIDDLEZON PG,ROUT D. Localization of the human estrogen receptor gene to chromosome 6 q24- q27 by in situ hybridization[J].Cytogenet Cell Genet, 1986,43(3):218- 220. 被引量:1
  • 8PONGLIKITOMONGKOL M,GREEN S,CHAMBON P. Genomic organization of the human estrogen receptor geme[J]. EMBO J ,1988,7(11):3385- 3388. 被引量:1
  • 9MORRISON NA,QI JC, TOKITA A, et al. Prediction of bone density from vitamin D receptor alleles[J]. Nature, 1994,367:284- 287. 被引量:1
  • 10王启俊,李玲,祝伟星,邢秀梅,周燕荣.中国城市居民乳腺癌危险因素的研究[J].中华流行病学杂志,2000,21(3):216-220. 被引量:77

共引文献35

同被引文献22

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部